The FDA approved Idacio as a biosimilar to Humira, a TNF inhibitor with indications for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s ...
Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In patients with psoriatic arthritis, upadacitinib showed greater improvement compared with both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback